BioLattice Ophthalmics, Inc,

Biotech Philadelphia, PA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Philadelphia, PA
Street
2929 Arch Street
Zip
19104

Offering

Total offering
$2.5M
Amount sold
$575k
First sale
Mar 6, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
2

How this filing compares

Ranked #14 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.5× the median.

Other Pennsylvania filings this week: 4401 Fund 4 LLC, Paragon Laboratories L.P., SEMPER VIC PARTNERS (QP), L. P., SEMPER VIC PARTNERS, L.P., 6 EMERY OWNER LLC

Leadership

Linda Alunkal — Executive Officer (also: Director)

Amelia Zellander — Executive Officer (also: Director)

Gregory Jackson — Director

Filing details

BioLattice Ophthalmics, Inc, filed a Form D with the SEC on March 30, 2026.

Other newest Biotech companies

Other newest companies in Pennsylvania